6/26/2025

Source: SeekingAlpha

6/25/2025

Here is how atai Life Sciences N.V. (ATAI) and Idexx Laboratories (IDXX) have performed compared to their sector so far this year.

Source: Yahoo

6/24/2025

WESTBROOK, Maine, June 24, 2025--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 second quarter financial results for Monday, August 4, 2025, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. EDT on that day.

Source: Yahoo

6/24/2025

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day

Source: MarketWatch

6/23/2025

For 1Q2025, Macquarie Mid Cap Growth Fund Institutional Class shares underperformed the Fund’s benchmark, the Russell Midcap Growth Index. Read more here.

Source: SeekingAlpha

6/23/2025

Source: SeekingAlpha

6/17/2025

IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day

Source: MarketWatch

6/17/2025

IDEXX Laboratories Inc. (NASDAQ:IDXX) is among the 12 best healthcare stocks. On June 11, Leerink Partners analyst Daniel Clark reiterated an Outperform rating on the stock. However, the analyst increased his stock price target to $580 from $515. According to the analyst IDEXX Laboratories has evolved to become the largest player in the veterinarian space. […]

Source: Yahoo

6/12/2025

BAMCO's Q1 2025 portfolio focuses on long-term growth, with top holdings in Tesla and MSCI. Baron Capital’s funds continue to outperform benchmarks. See more here.

Source: SeekingAlpha

6/12/2025

The main point of investing for the long term is to make money. Furthermore, you'd generally like to see the share...

Source: Yahoo

6/9/2025

IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors

Source: MarketWatch

6/5/2025

IDEXX Laboratories (NasdaqGS:IDXX) recently introduced its Catalyst® Cortisol Test, an advance in veterinary diagnostics, and reported an earnings growth with a raised revenue guidance for 2025. Furthermore, the company repurchased 930,800 shares, indicating strong financial health. These developments likely supported IDEXX's 22% share price increase over the last quarter. Meanwhile, broader market movements were relatively modest, with indices experiencing slight gains amid optimistic trade...

Source: Yahoo

6/5/2025

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the launch of the Catalyst® Cortisol Test, which measures real-time quantitative cortisol concentrations to support the diagnosis of Addison's disease and diagnosis and management of Cushing's syndrome in dogs. IDEXX's Catalyst Cortisol Test is the third menu expansion in under a year for the Catalyst platform, further advancing the diagnostic capabilities available to veterinary practices at t

Source: Yahoo

6/5/2025

IDEXX Laboratories, Inc. announced the launch of the Catalyst®? Cortisol Test, which measures real-time quantitative cortisol concentrations to support the diagnosis of Addison's disease and...

Source: Finnhub

6/5/2025

IDEXX Laboratories Inc: * IDEXX LABORATORIES - LAUNCHES CATALYST CORTISOL TEST FORDIAGNOSING ADDISON'S DISEASE AND MANAGING CUSHING'S SYNDROME INDOGSSource text:Further company...

Source: Finnhub

5/30/2025

The Multi Cap Equity Fund’s Institutional Class returned +0.81% for the quarter, comparing favorably to the Russell 3000 Index’s loss of -4.72%.

Source: SeekingAlpha

5/30/2025

Source: SeekingAlpha

5/28/2025

Source: SeekingAlpha

5/28/2025

Presenter SpeechJohn Ravis Next up, we have IDEXX Laboratories, the worldwide leader in animal health diagnostics. And joining me on the stage is the company's relatively new CFO, Andrew Emerson....

Source: Finnhub

5/28/2025

For the quarter, the Baird Mid Cap Growth portfolio produced a negative return of -9.6%, net of fees, trailing the Russell Midcap Growth decline of -7.1%.

Source: SeekingAlpha